Condition
Peritoneal Carcinomatosis clinical trials and research
As of November 12, 2026, Find a Trial lists 26 Peritoneal Carcinomatosis clinical trials that are recruiting, at sites in 13 countries (most in United States (11), Belgium (3), France (3)). By phase: Phase 2 (8), Phase 1 (5), Early Phase 1 (1), Phase 4 (1). The most active sponsors are Hospices Civils de Lyon (2), University of California, Irvine (2). There are also 1 NIH-funded research project on Peritoneal Carcinomatosis, with $521,240 in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 26Clinical trials
- 1NIH research projects
- 13Countries
Newest Peritoneal Carcinomatosis clinical trials
All recruiting trials (26)
-
Repeated PIPAC plus standard platinum–taxane chemotherapy for advanced ovarian cancer with peritoneal spread
This test sees if adding repeated cisplatin-based PIPAC to standard platinum–taxane chemotherapy helps women aged 18–75 with newly diagnosed FIGO IIIB–IIIC epithelial ovarian cancer and visible peritoneal carcinomatosis.
-
Enhanced Recovery After Surgery for adults with peritoneal carcinomatosis undergoing cytoreductive surgery with or without HIPEC
This project will try an Enhanced Recovery After Surgery (ERAS) program to see if it shortens hospital stays after cytoreductive surgery with or without HIPEC for adults with peritoneal carcinomatosis.
-
PIPAC with Mitomycin C for unresectable peritoneal cancer
This phase 1 study tests a breathy, pressurized chemotherapy method (PIPAC-MMC) to see if it is safe and tolerable for adults with unresectable peritoneal carcinomatosis from colorectal, appendiceal, or small bowel cancers.
-
Heated versus aerosolized chemotherapy delivered into the abdomen for cancer that has spread to the peritoneum
This study will test whether heated (HIPEC) or aerosolized (PIPAC) mitomycin-based chemotherapy given into the abdomen works better and is safer for adults whose cancer has spread to the peritoneum.
-
Adding paclitaxel into the abdominal cavity for gastric cancer that has spread to the peritoneum
This trial will try adding paclitaxel delivered directly into the abdomen to standard IV chemotherapy for people with gastric or gastroesophageal junction cancer that has spread to the lining of the abdominal cavity to see if it slows disease growth and helps them live longer.
-
Blood clearance of nucleosomes and CTCF after surgery for colorectal cancer with peritoneal spread
This test will see if blood levels of nucleosomes and CTCF can indicate whether adults with colorectal cancer that has spread to the peritoneum have had all visible tumor removed by cytoreductive surgery.
-
Mesothelin-targeted CAR T-cell therapy for esophagogastric cancer
This study is testing a new treatment that uses modified immune cells to target and attack tumors in people with advanced esophagogastric cancer.
-
Using pafolacianine for imaging during surgery for gastrointestinal cancer
This study is testing if a special imaging drug called pafolacianine can help doctors find cancer spots better during surgery for adults with gastrointestinal cancer.
-
Evaluating Radspherin® for Advanced Epithelial Cancer with Peritoneal Metastasis
This study is testing a new treatment called Radspherin® to see if it can help people with advanced ovarian or related cancers that have spread in the abdomen feel better and improve their chances after surgery.
-
Using Ga68-FAPI-46 PET/CT to assess peritoneal carcinomatosis before surgery
This study is testing a new type of imaging scan to see if it can better detect cancer spread in the abdomen before surgery for people with colorectal and ovarian cancer.
-
Modified early post-operative intraperitoneal chemotherapy for cancer treatment
This study is testing a new way of giving chemotherapy right after surgery to see if it works better and is safer for people with cancer that has spread in the abdomen.
-
Creating a model using patient samples for gastrointestinal cancer research
This study is trying to create a model using samples from patients with gastrointestinal cancer to better understand the disease and find better treatments.
-
Predicting responses to chemotherapy in gastrointestinal cancer using organoids
This study is testing if lab-grown mini tumors from patients with gastric or colon cancer can help doctors find the best chemotherapy drugs to improve treatment outcomes.
-
Assessing HIPEC with Mitomycin C for Colon Cancer with Peritoneal Metastases
This study is testing if a heated chemotherapy treatment called HIPEC with Mitomycin C can help people with colon cancer that has spread to the abdominal lining do better after surgery.
-
Personalized chemotherapy for abdominal cancer treatment
This study is testing a new way to personalize chemotherapy for patients with abdominal cancer by trying different treatments on their tumor samples before using them during surgery.
-
Combination therapy for gastric cancer with inoperable bowel obstruction
This study is testing a combination of three cancer drugs to see if it can help people with gastric cancer and a blocked bowel feel better and improve their condition.
-
Combination of PIPAC and systemic chemotherapy for advanced ovarian cancer
This study is testing a new way to give chemotherapy for women with advanced ovarian cancer who haven't responded well to previous treatments, by combining a special spray method with regular chemotherapy to see how safe it is and what the best dose is.
-
Comparing flat dose and weight-based chemotherapy for peritoneal carcinomatosis
This study is testing whether giving a flat dose or a dose based on body weight of a chemotherapy drug can help people with certain cancers that have spread to the abdominal area do better after surgery.
-
Aerosol chemotherapy for advanced gastric cancer treatment
This study is testing a new way of delivering chemotherapy directly to tumors in people with advanced stomach cancer to see if it helps them live longer and feel better compared to standard treatment.
-
Surgery and chemotherapy for gastric cancer with peritoneal spread
This study is testing if a combination of surgery and specific chemotherapy can help people with advanced stomach cancer that has spread to the lining of the abdomen feel better and control their disease for at least six months.
-
Using pressurized aerosol chemotherapy to treat advanced abdominal cancers
This study is testing a new way to deliver chemotherapy directly into the abdomen using a special aerosol spray to see if it helps people with advanced abdominal cancers feel better and have fewer side effects.
-
Study on the effects of surgery and HIPEC for peritoneal carcinomatosis
This study is testing how surgery and a special type of heated chemotherapy can affect the immune system and gut bacteria in people with peritoneal carcinomatosis to see how it impacts their health and recovery.
-
Effects of heated chemotherapy on advanced gastric cancer
This study is testing if a special heated chemotherapy treatment can help people with advanced gastric cancer feel better by boosting their immune response more than regular chemotherapy.
-
Using cardiac coherence to reduce anxiety in patients with peritoneal carcinosis before surgery
This study is testing if teaching patients with peritoneal carcinosis some breathing techniques can help reduce their anxiety before surgery.
-
Pressurized Chemotherapy for High Risk Colon Cancer Patients
This study is testing a new type of chemotherapy for patients with high-risk colon cancer to see if it can help prevent cancer from coming back after surgery and standard treatment.
-
Registering patients undergoing heated chemotherapy for peritoneal cancers
This study is collecting information from patients with certain abdominal cancers who are having surgery followed by heated chemotherapy to see if it helps them live longer and feel better.
NIH-funded research (1)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
A new model to study the spread of deadly colorectal and gastric cancers.
This study is creating a special lab model to learn more about how cancer spreads in the abdomen, which could help improve treatments for patients with colorectal and gastric cancer.
Related topics
Quick answers
How many Peritoneal Carcinomatosis clinical trials are recruiting right now?
26, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 13 countries. The most sites are in United States (11 trials), Belgium (3 trials), France (3 trials), Germany (2 trials), Italy (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 8, Phase 1: 5, Early Phase 1: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.